Press release
Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market to Receive Overwhelming Hike in Revenues by 2027
Read Report Overview - https://www.transparencymarketresearch.com/exocrine-pancreatic-insufficiency.html
Overview
Exocrine pancreatic insufficiency occurs when the pancreas does not release enough digestive enzymes. As a result, food is not digested properly, and the body doesn't receive the nutrition it needs. In people with chronic pancreatitis, EPI tends to develop 5 to 10 years after the onset of chronic pancreatitis and is present in 30-90% of patients.
The exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market is currently booming one, owing to rise in demand for the products, increase in awareness about technological products. Moreover the strong pipeline and strategic investment by key players are the factors anticipated to drive the growth of market.
Request for Report Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2748
North America dominates the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market in 2018 and the trend is anticipated to continue during the forecast period. The growth of market in the region is attributed due to higher cost of prescription in the U.S., surge in demand for EPI therapeutics, and well established healthcare infrastructure
Asia Pacific is likely to be a highly lucrative market for the exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market and it is expected to expand at a high CAGR during the forecast period. Vast patient pool, increasing healthcare expenditure and demand for newer advanced therapies are key factors likely to boost exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market in Asia Pacific.
Rise in Prevalence of Exocrine Pancreatic Insufficiency Disease to Drive Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market
Chronic & acute pancreatitis, autoimmune pancreatitis, pancreatic cancer, cystic fibrosis, diabetes, inflammatory bowel disease, celiac disease and among others are the diseases leading to cause of EPI. Thus, surge in number of people above mention causative condition is anticipated to drive the growth of market.
Request for Analysis of COVID-19 Impact on Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2748
Therapeutics Segment to Dominate Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market
In terms of type, the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market has been segmented into therapeutics and diagnostics. Demand for therapeutic products is anticipated to rise during the forecast period, owing to consolidation of brands and value generating brands such as Creon. This in turn to drive the growth of segment.
Diagnostics segment further sub-divided into blood tests, endoscopic ultra-sonography (EUS), magnetic resonance imaging (MRI) and CT scanning. The CT scanning sub-segment accounted for major share of the segment and continue its dominance during the forecast period. CT scanning helps in understanding the cause of pancreatic insufficiency, to detect previously undiagnosed carcinoma, enable diagnosis of chronic pancreatitis, and to confirm complete surgical removal of the pancreas. This in turn to increase in usage of CT scanning for diagnosis of exocrine pancreatic insufficiency and thereby drive the growth of segment
Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2748
North America to Dominate Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market
In terms of region, the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market in 2018, followed by Europe.
North America accounted for major share of the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market in 2018. High disease prevalence, supportive healthcare and payer infrastructure, and hub for key industry players are the major drivers of the exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market in the region.
The exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. Unmet medical needs, untapped nature of the market, increase in awareness about diseases such as cystic fibrosis and chronic pancreatitis and improving health care infrastructure are the key factors for exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market growth in the region
Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=2748
Competitive Landscape
The global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market is fragmented in terms of number of players. Key players in the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market include AbbVie, Inc., Allergan plc, Nordmark Arzneimittel GmbH & Co. KG, Digestive Care, Inc., Janssen Pharmaceuticals, Inc., Cilian AG, Anthera Pharmaceuticals, Inc. and AzurRx Biopharma, Inc.
More Trending Reports by Transparency Market Research -
Heart Pump Devices Market: http://www.prnewswire.com/news-releases/serious-lack-of-donors-of-organs-is-helping-to-increasing-popularity-of-heart-pump-devices-market-valuation-to-rise-up-to-us4-3-bn-by-2027--notes-tmr-301026081.html
Veterinary Endoscopes Market: https://www.prnewswire.com/news-releases/close-relationships-with-companion-animals-favoring-adoption-of-minimally-invasive-procedures-to-alleviate-post-surgical-pain-charts-growth-in-veterinary-endoscopes-market-market-projected-to-expand-at-a-cagr-of-7-1-from-2019---301247245.html
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market to Receive Overwhelming Hike in Revenues by 2027 here
News-ID: 2567534 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for EPI
Consumer Electronics Adoption Fuels The Silicon Epi Wafer Market: Core Growth En …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Will the Silicon EPI Wafer Industry Market Size Be by 2025?
Over recent years, the market size for silicon EPI wafers has seen considerable growth. Predictions indicate an increase from $1.8 billion in 2024 to $1.92 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this historical…
Evolving Market Trends In The Silicon EPI Wafer Industry: Next-Generation Silico …
The Silicon EPI Wafer Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Silicon EPI Wafer Market Size During the Forecast Period?
In recent times, the silicon EPI wafer market has witnessed substantial growth. The market size, which stood at $1.8 billion in…
Leading Growth Driver in the Silicon EPI Wafer Market in 2025: Consumer Electron …
What industry-specific factors are fueling the growth of the silicon epi wafer market?
The silicon EPI wafer market is expected to experience significant growth due to the increased use of consumer electronics products. Consumer electronics (CE) refers to electronic devices specifically designed for everyday use by consumers for non-commercial or professional purposes. Silicon wafers, which are semiconductors, are used in the manufacture of microchips and chips for these electronic devices. For…
EPI Invests $1 Million USD in the EPI Data Center Futurist Scholarship Program
Singapore (15 June 2023) - EPI, the global leader in data center training, audit & certification, is proud to announce the launch of the EPI Data Center Futurist Scholarship program, accompanied by a significant investment of one (1) million US-Dollar. This transformative initiative aims to provide aspiring professionals with the resources and support they need to acquire the specialized knowledge and skills necessary for success in the dynamic data…
Epi Wafer Market to Surpass Valuation of US$ 5.8 Bn by 2030 with Rising Demand f …
The global Epi Wafer market is estimated to attain a valuation of US$ 5.8 billion by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6% during the forecast period, 2021-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of…
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease.
Download the sample report at: https://www.pharmaproff.com/request-sample/1024
Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI…
